X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/moleculin-announces-presentation-of-positive-data-demonstrating-high-anti-cancer-activity-of-annamycin-and-non-cardiotoxic-properties-302112418.html
https://www.prnewswire.com/news-releases/moleculin-announces-positive-interim-data-in-annamycin-mb-106-phase-1b2-aml-trial-302097561.html
https://www.prnewswire.com/news-releases/moleculin-announces-positive-interim-data-in-annamycin-clinical-trials-mb-106-aml-trial-complete-response-cr-rate-of-38-and-mb-107-sts-lung-mets-trial-median-phase-1b-extended-overall-survival-of-11-months-301985417.html
https://www.prnewswire.com/news-releases/moleculin-doses-first-subjects-in-phase-2-portion-of-clinical-trial-evaluating-annamycin-in-combination-with-cytarabine-ara-c-for-the-treatment-of-acute-myeloid-leukemia-aml-301943789.html
https://www.prnewswire.com/news-releases/moleculin-announces-new-positive-independent-report-of-no-cardiotoxicity-in-annamycin-301930336.html
https://www.prnewswire.com/news-releases/moleculin-successfully-completes-first-cohort-in-phase-1b2-trial-evaluating-annamycin-in-combination-with-cytarabine-ara-c-for-the-treatment-of-acute-myeloid-leukemia-aml-301812483.html
https://www.clinicaltrialsarena.com/news/italy-moleculin-leukaemia-trial/
https://www.prnewswire.com/news-releases/moleculin-concludes-phase-1b-and-opens-recruitment-in-phase-2-clinical-trial-of-annamycin-for-the-treatment-of-soft-tissue-sarcoma-lung-metastases-301594892.html
https://www.prnewswire.com/news-releases/moleculin-announces-presentation-of-positive-preclinical-annamycin-data-at-the-aacr-2022-annual-meeting-301520605.html
https://www.prnewswire.com/news-releases/moleculin-announces-preliminary-third-cohort-interim-data-in-phase-1b2-clinical-trial-of-annamycin-for-the-treatment-of-soft-tissue-sarcoma-lung-metastases-301450820.html
https://www.prnewswire.com/news-releases/moleculin-announces-interim-data-in-phase-1b2-clinical-trial-of-annamycin-for-the-treatment-of-soft-tissue-sarcoma-lung-metastases-301401833.html
https://www.prnewswire.com/news-releases/moleculin-receives-approval-to-extend-dose-escalation-in-phase-12-european-clinical-trial-evaluating-annamycin-for-the-treatment-of-acute-myeloid-leukemia-301332047.html
https://www.prnewswire.com/news-releases/moleculin-announces-first-subject-enrolled-and-dosed-in-phase-1b2-clinical-trial-of-annamycin-for-the-treatment-of-sarcoma-lung-metastases-301316273.html
https://www.clinicaltrialsarena.com/news/moleculin-receives-grant-for-phase-ib-ii-sarcoma-trial-of-annamycin/
https://www.prnewswire.com/news-releases/moleculin-announces-annamycin-receives-fda-orphan-drug-designation-for-soft-tissue-sarcomas-301198841.html#:~:text=Moleculin%20recently%20announced%20that%20the,line%20therapy%20for%20their%20disease.
https://www.prnewswire.com/news-releases/moleculin-announces-annamycin-receives-fda-orphan-drug-designation-for-soft-tissue-sarcomas-301198841.html#financial-modal
https://www.prnewswire.com/news-releases/moleculin-announces-preclinical-data-confirms-efficacy-of-annamycin-in-lung-metastases-301083406.html
https://www.prnewswire.com/news-releases/moleculin-announces-trading-halt-301052411.html
https://www.wpdpharmaceuticals.com/_resources/news/April-23-2020.pdf
https://ir.moleculin.com/press-releases/detail/150/moleculin-announces-successful-completion-of-us-phase-1-aml
https://www.prnewswire.com/news-releases/moleculin-increases-annamycin-production-due-to-positive-clinical-trial-activity-and-expanded-potential-indications-300942606.html
https://www.prnewswire.com/news-releases/moleculin-announces-additional-positive-interim-results-in-first-cohort-of-phase-12-clinical-studies-of-annamycin-in-acute-myeloid-leukemia-in-europe-300844865.html
https://www.prnewswire.com/news-releases/moleculin-receives-fda-approval-of-fast-track-designation-for-annamycin-300834393.html
https://globenewswire.com/news-release/2019/01/09/1682683/0/en/Moleculin-Announces-Patient-Recruitment-Begins-in-Annamycin-Clinical-Trial-In-Poland.html
Market Place
Share 
